ArticleCancer research2017

Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire.

David Y Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.